SCHEMBL21727726

SCHEMBL21727726

CCc1cc(CC)cc(CCO)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ ALOX5 P09917 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ BACE1 P56817 1/20 0.41
▸ CYP4F2 P78329 4/20 0.38
▸ CYP4A11 Q02928 4/20 0.38
▸ RXRA P19793 1/20 0.38
▸ RXRB P28702 1/20 0.38
▸ TRPA1 O75762 1/20 0.37
▸ PTGS2 P35354 3/20 0.36
▸ CYP3A4 P08684 1/20 0.34
▸ GPR84 Q9NQS5 2/20 0.34
▸ TAAR1 Q96RJ0 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ HSPA5 P11021 1/20 0.33
▸ NPC1 O15118 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22169009 0.89 CA2 (0.38) CA2TDP1KDM4EALDH1A1ALOX5
SCHEMBL63871 0.85 TDP1 (0.53) CA2TDP1KDM4EALDH1A1ALOX5
SCHEMBL29331586 0.85 CA2 (0.40) CA2TDP1KDM4EALDH1A1ALOX5
SCHEMBL17277559 0.83 MAOA (0.41) CA2PTGS2CYP3A4GPR84TAAR1
SCHEMBL9490042 0.82 PTGS2 (0.42) RXRARXRBTRPA1PTGS2CYP3A4
SCHEMBL1247008 0.80 CYP4F2 (0.55) TDP1KDM4EALDH1A1ALOX5GAA
SCHEMBL28806252 0.78 PTGS2 (0.48) CA2TDP1ALDH1A1GAAMAPT
SCHEMBL439074 0.78 PTGS2 (0.48) CA2TDP1ALDH1A1GAAMAPT
SCHEMBL6418650 0.78 PGK1 (0.44) CA2TDP1KDM4EALDH1A1ALOX5
SCHEMBL81550 0.78 CA2 (0.59) CA2TDP1KDM4EALDH1A1ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3094318-B1 NOVEL FUNCTIONALIZED 1,3-BENZENE DIOLS AND THEIR METHOD OF USE FOR THE TREATMENT OF HEPATIC ENCEPHALOPATHY KANNALIFE SCIENCES INC (US) 2020-02-19 — — EP disclosed
Send feedback